Latest News

STAT Plus: Pharmalittle: Big pharma isn’t stepping up to make a coronavirus vaccine; Chinese drug maker threatens Gilead patent




Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember, there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Remember that no prescription is required. Our choice today is peppermint mocha. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day and please do stay in touch.

No major pharmaceutical company has come forward to say it would manufacture a vaccine for the novel coronavirus currently being developed by the National Institutes of Health, a reality that a top U.S. official called “very difficult and very frustrating,” STAT reports. The comments by Dr. Anthony Fauci, who heads the National Institute of Allergy and Infectious Diseases, highlight how challenging it could be to translate NIH work, being undertaken in partnership with Moderna Therapeutics (MRNA), into a vaccine that could be marketed.

Continue to STAT Plus to read the full story…

Source link





Related posts

Akrevia launches with $30M in Series A financing

Newsemia

Eiken Chemical Co Ltd – Product Pipeline Analysis, 2019 Update – ResearchAndMarkets.com

Newsemia

How does cannabis affect cognitive processing in young adults?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy